drugset / Trial / NCT00943709
Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
Phase 3
Withdrawn
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI) · collabSanofi · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
RATIONALE: Controlling blood sugar levels may be effective in preventing infections in patients receiving chemotherapy for acute myeloid leukemia or acute lymphoblastic leukemia. PURPOSE: This randomized phase I trial is studying how well controlling blood sugar levels works in preventing infection in patients with acute myeloid leukemia or acute lymphoblastic leukemia.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | — | Subcutaneous |
| Subject | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |